# Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia

> **NCT07685717** · PHASE2 · RECRUITING · sponsor: **Jennifer Woyach** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bone Marrow Aspiration
- **PROCEDURE:** Bone Marrow Biopsy
- **PROCEDURE:** Computed Tomography
- **OTHER:** Electronic Health Record Review
- **DRUG:** Pirtobrutinib
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT07685717
- **Lead sponsor:** Jennifer Woyach
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-13
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685717, "Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*